{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:42:24Z","timestamp":1772062944059,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s11894-004-0070-x","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T23:00:48Z","timestamp":1179615648000},"page":"482-487","source":"Crossref","is-referenced-by-count":34,"title":["Relevance of serologic studies in inflammatory bowel disease"],"prefix":"10.1007","volume":"6","author":[{"given":"Gwenola","family":"Vernier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boualem","family":"Sendid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fr\u2019ed\u2019eric","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/bega.2002.0347","volume":"17","author":"D Reumaux","year":"2003","unstructured":"Reumaux D, Sendid B, Poulain D, et al.: Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol 2003, 17:19\u201335.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"70_CR2","first-page":"63","volume-title":"The Inflammatory Bowel Disease Yearbook 2003","author":"JF Colombel","year":"2003","unstructured":"Colombel JF, Reumaux D, Sendid B, et al.: Serodiagnostics in IBD. In The Inflammatory Bowel Disease Yearbook 2003. Edited by Bernstein CN. London: Remedica; 2003:63\u201378."},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00384-003-0557-1","volume":"19","author":"FH Klebl","year":"2004","unstructured":"Klebl FH, Bataille F, Hofstadter F, et al.: Optimising the diagnostic value of Anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn\u2019s disease. Int J Colorectal Dis 2004, 19:319\u2013324.","journal-title":"Int J Colorectal Dis"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/CDLI.3.2.219-226.1996","volume":"3","author":"B Sendid","year":"1996","unstructured":"Sendid B, Colombel JF, Jacquinot PM, et al.: Specific antibody response to oligomannosidic epitopes in Crohn\u2019s disease. Clin Diagn Lab Immunol 1996, 3:219\u2013226.","journal-title":"Clin Diagn Lab Immunol"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"A112","DOI":"10.1016\/S0016-5085(04)80005-2","volume":"126","author":"P Vandewalle","year":"2004","unstructured":"Vandewalle P, Standaert A, Seddik M, et al.: A new ASCA test based on synthetic oligomannosides epitopes complements ASCA detection in both Crohn\u2019s disease and indeterminate colitis [abstract]. Gastroenterology 2004, 126:A112.","journal-title":"Gastroenterology"},{"key":"70_CR6","doi-asserted-by":"crossref","unstructured":"Joossens S, Vermeire S, Van Steen C, et al.: Pancreatic autoantibodies in inflammatory bowel disease. Inflamm Bowel Dis 2004, in press.","DOI":"10.1097\/00054725-200411000-00012"},{"key":"70_CR7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","volume":"123","author":"CJ Landers","year":"2002","unstructured":"Landers CJ, Cohavy O, Misra R, et al.: Selected loss of tolerance evidenced by Crohn\u2019s disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002, 123:689\u2013699. The findings of this study suggest, as reflected in experimental models of IBD, that patients with Crohn\u2019s disease can have a loss of tolerance to specific bacterial antigens and can be classified into four groups depending on their antibody responses.","journal-title":"Gastroenterology"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00042737-200209000-00013","volume":"14","author":"RK Linskens","year":"2002","unstructured":"Linskens RK, Mallant-Hent RC, Groothuismink ZMA, et al.:Evaluation of serological markers to differentiate between ulcerative colitis and Crohn\u2019s disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Eur J Gastroenterol Hepatol 2002, 14:1013\u20131017.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"70_CR9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","volume":"113","author":"MJ Lodes","year":"2004","unstructured":"LodesMJ, Cong Y, Elson CO, et al.: Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004, 113:1296\u20131306. An outstanding study in which serologic expression cloning was used to identify an immunodominant antigen, CBir1 flagellin, to which strong B-cell and CD4+ T-cell responses occur in colitic mice. Approximately 50% of patients with Crohn\u2019s disease had serum reactivity to CBir1, whereas ulcerative colitis patients and control subjects had little or no reactivity. CBir1 is the first bacterial antigen inducing colitis in animals that also demonstrates an abnormal immune response in IBD.","journal-title":"J Clin Invest"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"A112","DOI":"10.1016\/S0016-5085(04)80005-2","volume":"126","author":"S Targan","year":"2004","unstructured":"Targan S, CJ L, Lodes M, et al.: Antibodies to a novel flagellin (CBir1) define a unique serologic response in Crohn\u2019s disease [abstract]. Gastroenterology 2004, 126:A112.","journal-title":"Gastroenterology"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1019926121972","volume":"22","author":"JG Damoiseaux","year":"2002","unstructured":"Damoiseaux JG, Bouten B, Linders AM, et al.: Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002, 22:281\u2013288.","journal-title":"J Clin Immunol"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00054725-200205000-00014","volume":"8","author":"JC Escher","year":"2002","unstructured":"Escher JC: Serologic tests are helpful in managing but not in diagnosing IBD. Inflamm Bowel Dis 2002, 8:230\u2013321.","journal-title":"Inflamm Bowel Dis"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1572-0241.2001.03618.x","volume":"96","author":"MC Dubinsky","year":"2001","unstructured":"Dubinsky MC, Ofman JJ, Urman M, et al.: Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001, 96:758\u2013765.","journal-title":"Am J Gastroenterol"},{"key":"70_CR14","first-page":"2333","volume":"97","author":"MC Dubinsky","year":"2002","unstructured":"Dubinsky MC, Johanson JF, Seidman EG, Ofman JJ. Suspected inflammatory bowel disease: the clinical and economic impact of competing diagnostic strategies. Am J Gastroenterol 2002, 97:2333\u20132342.","journal-title":"Am J Gastroenterol"},{"key":"70_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00054725-200209000-00003","volume":"8","author":"K Khan","year":"2002","unstructured":"Khan K, Schwarzenberg SJ, Sharp H, et al.: Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis 2002, 8:325\u2013329. A pediatric study showing that, as a diagnostic tool, serology adds little to common laboratory tests and clinical history.","journal-title":"Inflamm Bowel Dis"},{"key":"70_CR16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00054725-200405000-00010","volume":"10","author":"SK Gupta","year":"2004","unstructured":"Gupta SK, Fitzgerald JF, Croffie JM, et al.: Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Inflamm Bowel Dis 2004, 10:240\u2013244.","journal-title":"Inflamm Bowel Dis"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0016-5085(99)70087-9","volume":"116","author":"R Panaccione","year":"1999","unstructured":"Panaccione R, Sandborn WJ: Is antibody testing for inflammatory bowel disease clinically useful? Gastroenterology 1999, 116:1001\u20131002.","journal-title":"Gastroenterology"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","volume":"122","author":"S Joossens","year":"2002","unstructured":"Joossens S, Reinisch W, Vermeire S, et al.: The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002, 122:1242\u20131247. The only prospective study that assessed the usefulness of serologic markers in indeterminate colitis. Ninety-seven patients with an initial diagnosis of indeterminate colitis were analyzed for ANCA and ASCA. After a mean of 1 year of follow-up, a definitive diagnosis was reached in 31 of 97 (32%) patients. ASCA+\/ANCA-predicted Crohn\u2019s disease in 80% of indeterminate colitis patients, whereas ASCA-\/ANCA+ was predictive for ulcerative colitis in 64%. Nevertheless, 48.5% of indeterminate colitis patients did not have antibodies against ASCA or ANCA, thus limiting the clinical utility of serologic testing. The majority of these patients remain as having indeterminate colitis during their further clinical course, perhaps reflecting a distinct clinico-serologic entity.","journal-title":"Gastroenterology"},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/01.mcg.0000124026.92823.fc","volume":"38","author":"S Plevy","year":"2004","unstructured":"Plevy S: Do serological markers and cytokines determine the indeterminate? J Clin Gastroenterol 2004, 38:S51-S56.","journal-title":"J Clin Gastroenterol"},{"key":"70_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1572-0241.2004.04107.x","volume":"99","author":"J Aisenberg","year":"2004","unstructured":"Aisenberg J, Legnani PE, Nilubol N, et al.: Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 2004, 99:432\u2013441.","journal-title":"Am J Gastroenterol"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00054725-200309000-00003","volume":"9","author":"FH Klebl","year":"2003","unstructured":"Klebl FH, Bataille F, Bertea CR, et al.: Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn\u2019s disease. Inflamm Bowel Dis 2003, 9:302\u2013307.","journal-title":"Inflamm Bowel Dis"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2249.2003.02392.x","volume":"135","author":"LJ Walker","year":"2004","unstructured":"Walker LJ, Aldhous MC, Drummond HE, et al.: Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn\u2019s disease are associated with disease severity but not NOD2\/CARD15 mutations. Clin Exp Immunol 2004, 135:490\u2013496.","journal-title":"Clin Exp Immunol"},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","volume":"126","author":"WS Mow","year":"2004","unstructured":"Mow WS, Vasiliauskas EA, Lin YC, et al.: Association of antibody responses to microbial antigens and complications of small bowel Crohn\u2019s disease. Gastroenterology 2004, 126:414\u2013424. This study suggests that the cumulative presence and magnitude of response to microbial antigens may be a marker of complicated small bowel Crohn\u2019s disease phenotype.","journal-title":"Gastroenterology"},{"key":"70_CR24","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1111\/j.1572-0241.2003.07673.x","volume":"98","author":"A Teml","year":"2003","unstructured":"Teml A, Kratzer V, Schneider B, et al.: Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn\u2019s disease during steroid and 5-aminosalicylic acid treatment. Am J Gastroenterol 2003, 98:2226\u20132231.","journal-title":"Am J Gastroenterol"},{"key":"70_CR25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00054725-200405000-00009","volume":"10","author":"RB Canani","year":"2004","unstructured":"Canani RB, Romano MT, Greco L, et al.: Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn\u2019s disease. Inflamm Bowel Dis 2004, 10:234\u2013239.","journal-title":"Inflamm Bowel Dis"},{"key":"70_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1542-3565(03)00321-5","volume":"2","author":"B Desir","year":"2004","unstructured":"Desir B, Amre DK, Lu SE, et al.: Utility of serum antibodies in determining clinical course in pediatric Crohn\u2019s disease. Clin Gastroenterol Hepatol 2004, 2:139\u2013146.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"70_CR27","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/gast.2001.23966","volume":"120","author":"KD Taylor","year":"2001","unstructured":"Taylor KD, Plevy SE, Yang H, et al.: ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn\u2019s disease. Gastroenterology 2001, 120:1347\u20131355.","journal-title":"Gastroenterology"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/j.1572-0241.2002.05689.x","volume":"97","author":"N Esters","year":"2002","unstructured":"Esters N, Vermeire S, Joossens S, et al.: Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn\u2019s disease. Am J Gastroenterol 2002, 97:1458\u20131462.","journal-title":"Am J Gastroenterol"},{"key":"70_CR29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.49.5.671","volume":"49","author":"PR Fleshner","year":"2001","unstructured":"Fleshner PR, Vasiliauskas E, Kam LY, et al.: High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001, 49:671\u2013677.","journal-title":"Gut"},{"key":"70_CR30","first-page":"A69","volume":"126","author":"J Spivak","year":"2004","unstructured":"Spivak J, Targan S, Vasiliauskas E, et al.: Antibodies to I2 predict clinical response to fecal diversion in Crohn\u2019s disease [abstract]. Gastroenterology 2004, 126:A69.","journal-title":"Gastroenterology"},{"key":"70_CR31","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(04)16154-0","volume":"363","author":"RH Scofield","year":"2004","unstructured":"Scofield RH. Autoantibodies as predictors of disease. Lancet 2004, 363:1544\u20131546.","journal-title":"Lancet"},{"key":"70_CR32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, et al.: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380\u2013386.","journal-title":"Arthritis Rheum"},{"key":"70_CR33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, et al.: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526\u20131533.","journal-title":"N Engl J Med"},{"key":"70_CR34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/path.1276","volume":"199","author":"N Oshitani","year":"2003","unstructured":"Oshitani N, Hato F, Suzuki K, et al.: Cross-reactivity of yeast antigens in human colon and peripheral leukocytes. J Pathol 2003, 199:361\u2013367.","journal-title":"J Pathol"},{"key":"70_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200102000-00002","volume":"7","author":"S Vermeire","year":"2001","unstructured":"Vermeire S, Peeters M, Vlietinck R, et al.: Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001, 7:8\u201315.","journal-title":"Inflamm Bowel Dis"},{"key":"70_CR36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00042737-200312000-00005","volume":"15","author":"M Harrer","year":"2003","unstructured":"Harrer M, Reinisch W, Dejaco C, et al.: Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn\u2019s disease? Eur J Gastroenterol Hepatol 2003, 15:1281\u20131285.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-004-0070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-004-0070-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-004-0070-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T05:54:36Z","timestamp":1587534876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-004-0070-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s11894-004-0070-x","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}